Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition)

Mycoses. 2024 Sep;67(9):e13785. doi: 10.1111/myc.13785.

Abstract

Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.

Keywords: Trichophyton indotineae; diagnosis; prevention and control; resistant dermatophytes; treatment.

Publication types

  • Practice Guideline

MeSH terms

  • Antifungal Agents* / pharmacology
  • Antifungal Agents* / therapeutic use
  • Arthrodermataceae / drug effects
  • China
  • Consensus*
  • Drug Resistance, Fungal*
  • Humans
  • Tinea* / diagnosis
  • Tinea* / drug therapy
  • Tinea* / microbiology
  • Trichophyton / drug effects
  • Trichophyton / isolation & purification

Substances

  • Antifungal Agents